Amgen eyes expansion and acquires Turkish generics firm

Article Date: 26/04/2012 08:11
Amgen eyes expansion and acquires Turkish generics firm

Vacancy Search

Quick job search

Advanced Search

Latest News

Allergan deploys 'poison pill' defence on Valeant bid

Allergan deploys 'poison pill' defence on Valeant bid

Janssen's Sylvant wins FDA nod for rare blood disorder

Janssen's Sylvant wins FDA nod for rare blood disorder

Patients hail "fantastic news" as NICE backs Velcade

Patients hail "fantastic news" as NICE backs Velcade

Soliris gets orphan status for organ transplants

Soliris gets orphan status for organ transplants

Heat on Roche to cut Kadcyla price after NICE 'no'

Heat on Roche to cut Kadcyla price after NICE 'no'

AbbVie files hep C combo in the US

AbbVie files hep C combo in the US

US "urgently" needs new ways to incentivise pharma

US "urgently" needs new ways to incentivise pharma

Vietnam pharma market "to grow 20% to 2017"

Vietnam pharma market "to grow 20% to 2017"

Novartis 'transforms' itself with multi-billion-dollar GSK, Lilly deals

Novartis 'transforms' itself with multi-billion-dollar GSK, Lilly deals

How oncology, vaccines and OTC will look after pharma’s game of musical chairs

The unusual switcheroo pulled by GlaxoSmithKline and Novartis today will cause enormous changes to the landscape in the key areas of oncology and vaccines, as well as in the consumer health...
more news